KAUST and King Faisal Specialist Hospital and Research Centre (KFSH&RC) are collaborating to develop bioelectronic sensors for rapid pathogen detection. These sensors aim to provide cheap and accurate results, potentially replacing conventional lab tests. A COVID-19 saliva test developed by KAUST researchers showed comparable sensitivity to PCR tests with a 15-minute turnaround. Why it matters: This partnership accelerates the development of novel diagnostic tools, which could improve healthcare accessibility in remote areas and low-income countries within the region.
KAUST researchers collaborated to identify molecular pathways for plant biofortification of vitamin A. A KAUST group demonstrated high pressure conversion of carbon dioxide into useful products. Another team designed a biosensor using metal oxide transistors to detect glucose in saliva. Why it matters: These projects highlight KAUST's contributions to biotechnology, environmental sustainability, and healthcare through advanced materials and molecular techniques.
KAUST researchers have developed a saliva-powered microbial fuel cell (MFC) that generates electricity using electrogenic bacteria to consume waste and release electrons. The micro-MFC uses graphene as an anode and an air cathode, achieving high current densities (1190 A m-3). The MFC produced 40 times more power than through the use of a carbon cloth anode. Why it matters: This technology offers a novel way to power lab-on-chip or portable diagnostic devices, particularly in remote or dangerous areas, and may offer alternatives to energy-intensive water purification technologies.